136. First-In-Human Study of NS-065/NCNP-01; The Morpholino Based Antisense Oligonucleotide for Exon 53 Skipping in Duchenne Muscular Dystrophy
Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33741-8
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2015
Authors
Publisher
Elsevier BV